ANEB
Price
$1.59
Change
-$0.03 (-1.85%)
Updated
Jan 17 closing price
Capitalization
65.32M
19 days until earnings call
BCTX
Price
$0.38
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
16.89M
Ad is loading...

ANEB vs BCTX

Header iconANEB vs BCTX Comparison
Open Charts ANEB vs BCTXBanner chart's image
Anebulo Pharmaceuticals
Price$1.59
Change-$0.03 (-1.85%)
Volume$4.2K
Capitalization65.32M
BriaCell Therapeutics
Price$0.38
Change-$0.00 (-0.00%)
Volume$577.62K
Capitalization16.89M
ANEB vs BCTX Comparison Chart
Loading...
ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANEB vs. BCTX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANEB is a Hold and BCTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ANEB: $1.59 vs. BCTX: $0.38)
Brand notoriety: ANEB and BCTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANEB: 12% vs. BCTX: 35%
Market capitalization -- ANEB: $65.32M vs. BCTX: $16.89M
ANEB [@Biotechnology] is valued at $65.32M. BCTX’s [@Biotechnology] market capitalization is $16.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANEB’s FA Score shows that 0 FA rating(s) are green whileBCTX’s FA Score has 1 green FA rating(s).

  • ANEB’s FA Score: 0 green, 5 red.
  • BCTX’s FA Score: 1 green, 4 red.
According to our system of comparison, BCTX is a better buy in the long-term than ANEB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANEB’s TA Score shows that 6 TA indicator(s) are bullish while BCTX’s TA Score has 3 bullish TA indicator(s).

  • ANEB’s TA Score: 6 bullish, 3 bearish.
  • BCTX’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, ANEB is a better buy in the short-term than BCTX.

Price Growth

ANEB (@Biotechnology) experienced а +8.90% price change this week, while BCTX (@Biotechnology) price change was -6.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

ANEB is expected to report earnings on May 08, 2025.

BCTX is expected to report earnings on Oct 27, 2023.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANEB($65.3M) has a higher market cap than BCTX($16.9M). ANEB YTD gains are higher at: -5.357 vs. BCTX (-33.097). ANEB has higher annual earnings (EBITDA): -7.71M vs. BCTX (-29.87M). BCTX has more cash in the bank: 5.79M vs. ANEB (1.4M). ANEB (0) and BCTX (0) have equivalent revenues.
ANEBBCTXANEB / BCTX
Capitalization65.3M16.9M386%
EBITDA-7.71M-29.87M26%
Gain YTD-5.357-33.09716%
P/E RatioN/AN/A-
Revenue00-
Total Cash1.4M5.79M24%
Total DebtN/A27K-
FUNDAMENTALS RATINGS
BCTX: Fundamental Ratings
BCTX
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANEBBCTX
RSI
ODDS (%)
Bullish Trend 11 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 11 days ago
85%
Bullish Trend 11 days ago
81%
Momentum
ODDS (%)
Bullish Trend 11 days ago
87%
Bearish Trend 11 days ago
80%
MACD
ODDS (%)
Bullish Trend 11 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
85%
Bearish Trend 11 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
82%
Bearish Trend 11 days ago
85%
Advances
ODDS (%)
Bullish Trend 26 days ago
81%
Bullish Trend 16 days ago
81%
Declines
ODDS (%)
Bearish Trend about 1 month ago
85%
Bearish Trend 11 days ago
82%
BollingerBands
ODDS (%)
N/A
Bullish Trend 11 days ago
87%
Aroon
ODDS (%)
Bearish Trend 11 days ago
89%
N/A
View a ticker or compare two or three
Ad is loading...
ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EKJAX11.130.12
+1.09%
Allspring Premier Large Co Gr A
TAGRX68.230.64
+0.95%
JHancock Fundamental Large Cap Core A
FWOMX17.490.10
+0.58%
Fidelity Women's Leadership
TBWIX18.620.02
+0.11%
Thornburg Better World International I
LHCQX18.94-0.13
-0.68%
Lord Abbett Health Care R3

ANEB and

Correlation & Price change

A.I.dvisor tells us that ANEB and TECX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANEB and TECX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANEB
1D Price
Change %
ANEB100%
-1.55%
TECX - ANEB
31%
Poorly correlated
-2.67%
ALDX - ANEB
28%
Poorly correlated
+1.26%
BCTX - ANEB
26%
Poorly correlated
-1.82%
FBIO - ANEB
26%
Poorly correlated
-2.09%
SRPT - ANEB
25%
Poorly correlated
+0.80%
More

BCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCTX has been loosely correlated with SNPX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BCTX jumps, then SNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCTX
1D Price
Change %
BCTX100%
-1.82%
SNPX - BCTX
35%
Loosely correlated
N/A
KROS - BCTX
31%
Poorly correlated
+3.23%
MDGL - BCTX
30%
Poorly correlated
+7.64%
AXON - BCTX
30%
Poorly correlated
+1.37%
LSB - BCTX
30%
Poorly correlated
+16.12%
More